Pyxis Oncology, Inc. (PYXS) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts PYXS Hot Sheet
Join SI Premium – FREE
Pyxis Oncology, Inc. (NASDAQ: PYXS) reported Q1 EPS of ($0.35), $0.02 worse than the analyst estimate of ($0.33).
For earnings history and earnings-related data on Pyxis Oncology, Inc. (PYXS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- Boost Run posts Q2 revenue of $31.1M, up 270% year over year
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
